Evidence map›Paper›PMID 26216408›Full record

ArticleRadiation oncology (London, England)2015

Erratum: Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.

Antonio José Conde Moreno, Carlos Ferrer Albiach, Rodrigo Muelas Soria, Verónica González Vidal, Raquel García Gómez, María Albert Antequera

Abstract readPublished Erratum
In one paragraph

Article in Radiation oncology (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Antonio José Conde MorenoServicio de Oncología Radioterápica, Instituto Oncológico de Castellón "Dr. Altava", Consorcio Hospitalario Provincial de Castellón, Av. Dr. Clarà N 19, Castellón de la Plana, 12002, Castellón, Spain. antoniojconde@gmail.com.
Carlos Ferrer AlbiachServicio de Oncología Radioterápica, Instituto Oncológico de Castellón "Dr. Altava", Consorcio Hospitalario Provincial de Castellón, Av. Dr. Clarà N 19, Castellón de la Plana, 12002, Castellón, Spain. ferreralbiach@gmail.com.
Rodrigo Muelas SoriaServicio de Oncología Radioterápica, Instituto Oncológico de Castellón "Dr. Altava", Consorcio Hospitalario Provincial de Castellón, Av. Dr. Clarà N 19, Castellón de la Plana, 12002, Castellón, Spain. rodmuelas@hotmail.com.
Verónica González VidalServicio de Oncología Radioterápica, Instituto Oncológico de Castellón "Dr. Altava", Consorcio Hospitalario Provincial de Castellón, Av. Dr. Clarà N 19, Castellón de la Plana, 12002, Castellón, Spain. gonzalezvidalveronica@gmail.com.
Raquel García GómezServicio de Oncología Radioterápica, Instituto Oncológico de Castellón "Dr. Altava", Consorcio Hospitalario Provincial de Castellón, Av. Dr. Clarà N 19, Castellón de la Plana, 12002, Castellón, Spain. raquelitagarcia@gmail.com.
María Albert AntequeraServicio de Oncología Radioterápica, Instituto Oncológico de Castellón "Dr. Altava", Consorcio Hospitalario Provincial de Castellón, Av. Dr. Clarà N 19, Castellón de la Plana, 12002, Castellón, Spain. maria2albert@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26216408
PMCPMC4517639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.